2003

Wüster Chr, Gühring T, Wenzler M, Bickert B, Kappes J, Rehm C, Mende U. Metacarpal digital X-ray Radiogrammetry (DXR): German Reference Data for Males and Females. Calc Tiss Int, accepted for publication

Rosen C and Wüster Chr. Editorial: Growth Hormone Rising: Did We Quit Too Quickly? J Bone Miner Res 18:406-409 (2003)

Hadji P., Ziller V., Fischer F, Gottschalk M and Wüster Chr. Osteoporose-Diagnostik. Teil 1 und 2. Ars Medica 4+5/2003, 243-248 (2003)

2002

Feldt-Rasmussen U, Abs R, Bengtsson B-Å, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster Chr. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing’s disease. Eur J Endocrinology 146:67-74 (2002).

Kremer P, , M. Forsting, G. Ranaei, C.Wüster, J. Hamer, K. Sartor, and S. Kunze. Magnetic Resonance Imaging after Transsphenoidal Surgery of Clinically Non-Functional Pituitary Macroadenomas and its Impact on Detecting Residual Adenoma. Acta Neurochir (Wien) (2002) 144: 433–443

Hadji P, Goerke K, Wüster C, Gottschalk M, Lüttje D, Kneer W, Schulz KD. Osteodensitometrie: Indikationen, Ergebnisse, Methoden. Gynäkol. Prax 26, 449-458 (2002)

2001

Wüster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P. The Influence of Growth Hormone (GH) Deficiency, GH Replacement Therapy and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral density. J Bone Miner Res 16:398-405 (2001)

2000

C. Wüster, C. Albanese, D. de Aloysio, F. Duboeuf, M. Gambacciani, S. Gonnelli, C.-C Gluer, D. Hans, J. Joly, J.Y. Reginster, F. de Terlizzi, R. Cadossi for the PhOS study group. Phalangeal Osteosonogrammetry Study (PHOS): Age Related Changes, Diagnostic Sensitivity and Discrimination Power. J Bone Mineral Research, 15:1603-1614 (2000).

Wüster C. On the search for the osteoporosis genes: how many more do we need? European Journal of Clinical Investigation 30: 563-565; 2000

Wüster C. Fracture rates in patients with growth hormone deficiency. Hormone Research, 54: 31-35 (2000)

Wüster C, Pourfard J, Lüttje D, Kneer W und Hadji P. Osteodensitometrie: Möglichkeiten und Tücken. Geriatrie Journal 9: 17-21, 2000

Cowell CT, Wüster C. Preface. Hormone Research, 54:1-2 (2000)

Cadossi R, de Terlizzi F, Canè V, Fini M, Wüster C. Assessment of Bone Architecture with Ultrasonometry: Experimental and Clinical Experience. Hormone Research, 54:9-18 (2000)

Cowell CT, Wüster C. The effects of Growth Hormone Deficiency and Growth Hormone Replacement Therapy on Bone. A Meeting Report. Hormone Research, 54:68-74 (2000)

Monson JP, Bengtsson BA, Abs R, Feldt-Rsmussen U, Wüster C for the KIMS Strategic Committee. Can Growth hormone therapy cause diabetes? Lancet 355:1728 (letter) 2000.

Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: A population survey of older men and women. Osteoporosis International 11:102-119; 2000.

Schutz F, Wuster C, Heilmann P, Ziegler R, Hadji P. No advantage of the new combined octreotide-GHRH test over established GH-stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults. Clin Endocrinol (Oxf) 2000;53(6):667-674

Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wüster C. Growth hormone deficiency and replacement in elderly hypopituitary adults. Clin Endocrinology 53:281-289 (2000).

Kick G, Korting HC, Wüster C, Plewig G. Glucocorticosteroid-induced osteoporosis – Prevention and treatment by bisphosphonates. H+G Zeitschrift fur Hautkrankheiten, 2000, 75, (10) 575-580.

Fogelman I; Ribot C; Smith R; Ethgen D; Sod E; Reginster JY; Combe B; Fogelman I; Glowinski J; Pornel B; Mulder H; Ribot C; Smith I; Smith R; Walravens M; Wuster C. Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 85: 1895-1900; (2000)

1999

Wüster Chr, Hadji P, Blaul G, Naß-Grigoleit I. Quantative Knochenultrasonometrie (QUS) am Fersenbein zur Osteoporose – Diagnostik in der Bevölkerung. Zentralbl Gynäkol 121:137-142 (1999)

Wüster C, Hadji P. Use of quantitative ultrasound densitometry in male osteoporosis: Diagnosis and treatment. Aging Male 2(4): 228-239;(1999)

Hadji P, Hars O, Wüster Chr, Bock K, Alberts US, Bohnet HG, Emons G, Schulz KD. Stiffness identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone. Maturitas 31:221-226 (1999).

Abs R, Bengtsson BÅ, Hernberg-Ståhl E, Monson J, Tauber JP, Wilton P, Wüster Chr. GH replacement in 1034 growth hormone deficient adults: demographic and clinical characteristics, dosing and safety. J Clin Endocrinol 50:703-713 (1999).

Bengtsson BÅ, Abs R, Hernberg-Ståhl E, Monson J, Tauber JP, Wilton P, Wüster Chr. The effects of treatment and the individual responsiveness to GH replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metabol 84: 3929–35,1999.

Bengtsson BA; Koppeschaar HPF; Abs R; Bennmarker H; Hernberg-Stahl E; Westberg B; Wilton P; Monson JP; Feldt-Rasmussen U; Wüster Chr. Growth Hormone replacement therapy is not associated with any increase in mortality. J Clin Endocrinol Metabol. 84: 4291-2 (1999)

Hadji P, Hars O, Schüler M, Bock K, Wüster Chr, Emons G, Schulz K-D. The Effect of Hormone Replacement Therapy on Quantitative Ultrasonometry. Am J Obstet Gynecology 1999, accepted for publication.

1998

Wüster Chr, Härle U, Rehn U, Müller C, Knauf K, Köppler D, Schwabe C, Ziegler R. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis. Growth Hormone and IGF Research 8:87-94 (1998).

Wüster Chr. Bisphosphonate bei Osteoporose und anderen Knochenerkrankungen. Der Kassenarzt 8:42-47 (1998)

Wüster Chr. Knochendichtemessung mittels Ultraschall – reif für die Praxis?. Zentralbl Gynäkol 120: 257-261 (1998)

Wüster, Chr, Soballa T, Heilmann P, Schlegel J, Cadossi R, Ziegler R. Use of ultrasonography in clinical practice: Normative data and discrimination power in osteoporosis. Menopause Review 1998.

Wüster C, Heilmann P, Pereira-Lima J, Schlegel J, Anstätt K, Soballa T. Quantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: Reference data for various measurement sites, limitations and application possiblities. Exp Clin Endocrinol Diabetes 106:277-288 (1998)

Wüster C, Engels K, Renner E, Hesch RD, Hadji P, Pourfard JY. Meßwertinterpretation in der Osteodensitometrie. Dtsch Ärztebl 95:2547-2551(1998) .

Wüster C, Melchinger U, Eversmann T, Hensen J, Kann P, von zur Mühlen A, Ranke MB, Schmeil H, Steinkamp H, Tuschy U für die Deutsche KIMS-Studiengruppe. Verminderte Inzidenz von Nebenwirkungen einer Wachstumshormonsubstitution bei 404 Patienten mit Hypophyseninsuffizienz. Med. Klinik 93:585-91 (1998).

Soballa Th, Schlegel J, Cadossi R, Isani R, Heilmann P, Ziegler R, Wüster Chr: Osteosonographie der Phalangen bei Männern. Med Klinik 93:131-6, 1998

Ranke MB, Wüster Chr. Wachstumshormon-Mangel: Von der Kindheit zum Erwachsenenalter. Der Kinderarzt 29: 306-8 (1998).

Alenfeld FE, Wüster C, Beck C, Pereira-Lima JFS, Fritz T, Meeder PJ, Ziegler R. Ultrasound measurements of the proximal phalanges in healthy and patients with hip fracture. Osteoporosis Int 8:393-8 (1998).

Heilmann P, Wüster C, Prolingheuer C, Götz M, Ziegler R. Measurements of Forearm bone mineral density (BMD: Comparison of short-time and long-time precision of five different instrument settings. Calcif Tiss Int 38:383 -387(1998)

Soballa Th, Wüster Chr, Schlegel J, Cadossi R, Isani R, Heilmann P, Ziegler R: Ultrasound transmission speed and ultrasound bone profile score (UBPS) of the phalanges in normals and women with osteoporosis. Hormone Metab Res, 30:536-541 (1998)

Scheidt-Nave Chr., Felsenberg D, Kragl G, Bruckner T, Leidig-Bruckner G, Wüster Chr, Ziegler R. Vertebrale Deformität als Index der osteoporotischen Wirbelfraktur – eine externe Konstruktvalidierung anhand von Knochendichtemessungen. Med. Klinik 93 (Suppl II):46-55 (1998).

Zipfel S, Specht T, Blum WE, Hebebrand J, Englaro P, Hartmann M, Wüster C, Ziegler R, and Herzog W. Leptin – a paramter for body fat measurement in patients with eating disorders. Eur Eat Disorders Rev 6: 38-47 (1998)

Klaus G, Paschen C, Wüster C, Kovacs GT, Barden J, Mehls O, Schärer K. Weight-/height – related bone mineral density is not reduced after renal transplantation. Pediatr Nephrol 12:343-348 (1998)

Hadji P, Wüster Chr, Emons G, Schulz KD. Prävention der Osteoporose – eine Herausforderung für die gynäkologische Praxis. Frauenarzt 39: 1864 – 1877 (1998)

1997

Wüster Chr. Parathyroid hormone – a new prognostic marker of mortality ? Eur J Clin Invest 27:982-983 (1997)

Wüster Chr , Heilmann P . Bisphosphonat-Therapie der Osteoporose – Hemmung der Trabekelperforation durch Aminobisposphonate. Fortschritte der Medizin 115:37-42 (1997)

Keilholz U., Max R., Scheibenbogen C., Wüster Chr., Körbling M., Haas R. Endocrine Function and Bone Metabolism 5 Years after Bone Marrow/Blood-Derived Progenitor Cell Transplantation. Cancer 79:1617-22 (1997).

1996

Wüster Chr. Therapie der manifesten Osteoporose. Geriatrie Praxis. 8:30-39 (1996).

Wüster, C. Hormonell bedingte Wachstumsstörungen, Diagnostik und Nachweismethoden. mta 11:884-890 (1996).

SH Scharla, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel MJ, Ziegler R. Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: A population-based study. Exp Clin Endocrinol Diabetes 104:289-292 (1996).

Funck C, Wüster C, Alenfeld FE, Pereira-Lima JFS, Fritz T, Meeder PJ, Götz M, Ziegler R. Ultrasound velocity of the tibia in normal German women and hip fracture patients. Calcif Tiss Int. 58: 390-394 (1996).

Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wüster C, Haack, Ziegler R. Relationsship between circulating insulin-like growth factor components and sex hormones in a population-basaed sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81:2534-40 (1996).

Woitge HW, Müller M, Bärtsch P, Friedmann B, Wüster C, Seibel MJ, Ziegler R. Physical activity increases bone formation and decreases bone resorption as assessed by biochemical markers of bone turnover. Clin Lab 42:1079-1083 (1996).

1985 – 1995

H.W. Minne, J. Pfeilschifter, F. Bauss, S. Scharla, S. Mutschelknauss, R. Egeler, K. Raab, C. Knopp, U. Wieland, M. Werner, Chr. Wüster, F. Raue, B. Krempien, S. Parvizi und R. Ziegler. Inflammations-mediierte Osteopenie (IMO): Beeinflußbarkeit des Serum-Calciums und der Knochenmasse ohne pathogenetische Beteiligung der Hormone der Calciumhomöostase. Akt Endokr Stoffw 6, 40-44, (1985)